Format
Sort by
Items per page

Send to

Choose Destination

Best matches for depression Meningococcal:

Search results

Items: 1 to 20 of 32

1.

Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial.

Misawa S, Kuwabara S, Sato Y, Yamaguchi N, Nagashima K, Katayama K, Sekiguchi Y, Iwai Y, Amino H, Suichi T, Yokota T, Nishida Y, Kanouchi T, Kohara N, Kawamoto M, Ishii J, Kuwahara M, Suzuki H, Hirata K, Kokubun N, Masuda R, Kaneko J, Yabe I, Sasaki H, Kaida KI, Takazaki H, Suzuki N, Suzuki S, Nodera H, Matsui N, Tsuji S, Koike H, Yamasaki R, Kusunoki S; Japanese Eculizumab Trial for GBS (JET-GBS) Study Group.

Lancet Neurol. 2018 Jun;17(6):519-529. doi: 10.1016/S1474-4422(18)30114-5. Epub 2018 Apr 21.

PMID:
29685815
2.

Meningococcal arthritis and myopericarditis: a case report.

Steele L, Bechman K, De Barra E, Mackworth-Young C.

BMC Infect Dis. 2017 Dec 6;17(1):751. doi: 10.1186/s12879-017-2845-3.

3.

ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.

Farraye FA, Melmed GY, Lichtenstein GR, Kane SV.

Am J Gastroenterol. 2017 Feb;112(2):241-258. doi: 10.1038/ajg.2016.537. Epub 2017 Jan 10. Review. Erratum in: Am J Gastroenterol. 2017 Jul;112(7):1208.

PMID:
28071656
4.

Honey and larvae in the treatment of foot gangrene: a reflection.

Dickinson R.

Br J Nurs. 2016 Nov 10;25(20 Suppl):S10-S14.

PMID:
27834532
5.

Preventative Care in the Patient with Inflammatory Bowel Disease: What Is New?

Reich JS, Farraye FA, Wasan SK.

Dig Dis Sci. 2016 Aug;61(8):2205-16. doi: 10.1007/s10620-016-4146-x. Epub 2016 Apr 9. Review.

PMID:
27061291
6.

Depressive symptoms and immune response to meningococcal conjugate vaccine in early adolescence.

O'Connor TG, Moynihan JA, Wyman PA, Carnahan J, Lofthus G, Quataert SA, Bowman M, Caserta MT.

Dev Psychopathol. 2014 Nov;26(4 Pt 2):1567-76. doi: 10.1017/S0954579414001242.

7.

Comparative long-term adverse effects elicited by invasive group B and C meningococcal infections.

Gottfredsson M, Reynisson IK, Ingvarsson RF, Kristjansdottir H, Nardini MV, Sigurdsson JF, Schneerson R, Robbins JB, Miller MA.

Clin Infect Dis. 2011 Nov;53(9):e117-24. doi: 10.1093/cid/cir500. Epub 2011 Sep 26.

8.

Myocardial depressant effects of interleukin 6 in meningococcal sepsis are regulated by p38 mitogen-activated protein kinase.

Pathan N, Franklin JL, Eleftherohorinou H, Wright VJ, Hemingway CA, Waddell SJ, Griffiths M, Dennis JL, Relman DA, Harding SE, Levin M.

Crit Care Med. 2011 Jul;39(7):1692-711. doi: 10.1097/CCM.0b013e3182186d27.

PMID:
21494108
9.

Disseminated intravascular coagulation, meningococcal infection, and ischemic changes affecting the lower extremities: a case study.

Herzog JL, Morgan KP, Paden MH, Stone PA.

J Foot Ankle Surg. 2010 Sep-Oct;49(5):489.e5-9. doi: 10.1053/j.jfas.2010.04.005.

PMID:
20619693
10.

Opa+ and Opa- isolates of Neisseria meningitidis and Neisseria gonorrhoeae induce sustained proliferative responses in human CD4+ T cells.

Youssef AR, van der Flier M, Estevão S, Hartwig NG, van der Ley P, Virji M.

Infect Immun. 2009 Nov;77(11):5170-80. doi: 10.1128/IAI.00355-09. Epub 2009 Aug 31.

11.

Outcomes of meningococcal disease in adolescence: prospective, matched-cohort study.

Borg J, Christie D, Coen PG, Booy R, Viner RM.

Pediatrics. 2009 Mar;123(3):e502-9. doi: 10.1542/peds.2008-0581.

PMID:
19254985
12.

Surviving meningococcal septic shock: health consequences and quality of life in children and their parents up to 2 years after pediatric intensive care unit discharge.

Buysse CM, Raat H, Hazelzet JA, Hop WC, Maliepaard M, Joosten KF.

Crit Care Med. 2008 Feb;36(2):596-602. doi: 10.1097/01.CCM.0000299740.65484.CA.

PMID:
18216608
13.

Acute flaccid paraplegia: a rare complication of meningococcal meningitis.

Rathore MF, Gill ZA, Malik AA, Farooq F.

Spinal Cord. 2008 Apr;46(4):314-6. Epub 2007 Sep 11.

PMID:
17846638
14.

Psychiatric adjustment in the year after meningococcal disease in childhood.

Shears D, Nadel S, Gledhill J, Gordon F, Garralda ME.

J Am Acad Child Adolesc Psychiatry. 2007 Jan;46(1):76-82.

PMID:
17195732
15.

Myocardial dysfunction in meningococcal septic shock.

Makwana N, Baines PB.

Curr Opin Crit Care. 2005 Oct;11(5):418-23. Review.

PMID:
16175027
16.

Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock.

Pathan N, Hemingway CA, Alizadeh AA, Stephens AC, Boldrick JC, Oragui EE, McCabe C, Welch SB, Whitney A, O'Gara P, Nadel S, Relman DA, Harding SE, Levin M.

Lancet. 2004 Jan 17;363(9404):203-9.

PMID:
14738793
17.

Characterization of a myocardial depressant factor in meningococcal septicemia.

Pathan N, Sandiford C, Harding SE, Levin M.

Crit Care Med. 2002 Oct;30(10):2191-8.

PMID:
12394943
18.

A myocardial cytotoxic process is involved in the cardiac dysfunction of meningococcal septic shock.

Thiru Y, Pathan N, Bignall S, Habibi P, Levin M.

Crit Care Med. 2000 Aug;28(8):2979-83.

PMID:
10966282
19.

Life-threatening heart failure in meningococcal septic shock in children: non-invasive measurement of cardiac parameters is of important prognostic value.

Hagmolen of ten Have W, Wiegman A, van den Hoek GJ, Vreede WB, Derkx HH.

Eur J Pediatr. 2000 Apr;159(4):277-82.

PMID:
10789934
20.

Current drug treatment strategies for disseminated intravascular coagulation.

de Jonge E, Levi M, Stoutenbeek CP, van Deventer SJ.

Drugs. 1998 Jun;55(6):767-77. Review.

PMID:
9617592

Supplemental Content

Loading ...
Support Center